首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Requirement for small side chain residues within the GxGD-motif of presenilin for gamma-secretase substrate cleavage.
【24h】

Requirement for small side chain residues within the GxGD-motif of presenilin for gamma-secretase substrate cleavage.

机译:早老素的GxGD基序中的小侧链残基需要进行γ-分泌酶底物裂解。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

gamma-Secretase is a pivotal intramembrane-cleaving protease complex and important drug target for Alzheimer's disease. The protease not only releases small peptides, such as the amyloid-beta peptide, which drives Alzheimer's disease pathogenesis, but also intracellular domains, which can have critical functions in nuclear signaling. Unlike typical aspartyl proteases, gamma-secretase contains a non-classical GxGD active site motif in its catalytic subunit presenilin (PS) 1 or PS2. It is not known whether both glycines are of similar functional relevance and why the glycine residues are invariant elements of the motif. Here we identify the N-terminal glycine of the GxGD motif in PS1, G382, as a critical residue of the active site domain of gamma-secretase. Substitution of G382 by a number of different amino acids abrogated gamma-secretase activity. Only the smallest possible G382A substitution allowed substantial gamma-secretase activity. Depending on the substrate, however, the presence of G382 could become even an absolute functional requirement of gamma-secretase. Very similar results were obtained for the C-terminal glycine residue (G384) of the GxGD motif. Our data thus identify a requirement for small side chain residues in the active site domain of gamma-secretase and suggest that the glycines of the GxGD motif could be evolutionary conserved to allow cleavage of all possible gamma-secretase substrates, including those, which are highly sensitive to minimal alteration of the PS active site domain. These findings broaden our understanding of gamma-secretase substrate recognition and cleavage, which may prove crucial for therapeutic targeting of the enzyme.
机译:γ-分泌酶是关键的膜内切割蛋白酶复合物,是阿尔茨海默氏病的重要药物靶标。该蛋白酶不仅释放驱动阿尔茨海默氏病发病机理的小肽(如淀粉样蛋白β肽),而且还释放细胞内结构域,这些结构域可能在核信号传导中起关键作用。与典型的天冬氨酰蛋白酶不同,γ-分泌酶在其催化亚基早老素(PS)1或PS2中包含非经典GxGD活性位点基序。尚不知道两个甘氨酸是否具有相似的功能相关性,以及为什么甘氨酸残基是基序的不变元件。在这里,我们将PS1 G382中GxGD基序的N末端甘氨酸鉴定为γ-分泌酶活性位点域的关键残基。用许多不同的氨基酸取代G382可以消除γ-分泌酶的活性。只有最小的可能的G382A取代才允许大量的γ-分泌酶活性。但是,取决于底物,G382的存在甚至可能成为γ-分泌酶的绝对功能要求。对于GxGD基序的C端甘氨酸残基(G384)获得了非常相似的结果。因此,我们的数据确定了对γ-分泌酶的活性位点域中的小侧链残基的需求,并表明GxGD基序的甘氨酸可以进化保守,以允许裂解所有可能的γ-分泌酶底物,包括高度分离的底物。对PS活动站点域的最小更改敏感。这些发现拓宽了我们对γ-分泌酶底物识别和裂解的理解,这可能证明对该酶的治疗靶向至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号